New treatment trial aims to give kids with kidney disease more time between Flare-Ups
Disease control
Not yet recruiting
This study is testing whether one dose or two doses of the medication ripertamab works better for children with a specific type of kidney disease that keeps coming back. The goal is to help children stay in remission longer and reduce their need for steroid medications, which can…
Phase: NA • Sponsor: Mao Jianhua • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC